HeartBeam (NASDAQ:BEAT) Issues Earnings Results

HeartBeam (NASDAQ:BEAT) announced its earnings results on Thursday. The medical research company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04, FiscalAI reports.

HeartBeam Price Performance

Shares of NASDAQ:BEAT traded down $0.01 during midday trading on Thursday, hitting $0.40. The company had a trading volume of 433,229 shares, compared to its average volume of 2,969,470. HeartBeam has a 12-month low of $0.35 and a 12-month high of $4.00. The company has a fifty day moving average of $0.43 and a two-hundred day moving average of $0.82. The company has a market cap of $22.75 million, a price-to-earnings ratio of -0.79 and a beta of -0.84.

Analyst Upgrades and Downgrades

Several brokerages recently commented on BEAT. Wall Street Zen raised HeartBeam to a “sell” rating in a report on Saturday, October 10th. Weiss Ratings raised HeartBeam from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, October 30th. Finally, HC Wainwright reissued a “neutral” rating on shares of HeartBeam in a research report on Tuesday, October 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $4.00.

HeartBeam Company Profile

HeartBeam, Inc. is a medical technology company developing portable and digital solutions for cardiac monitoring. Its proprietary technology is designed to capture, analyze and transmit electrocardiogram (ECG) data outside traditional clinical settings, with a focus on helping identify cardiac events such as atrial fibrillation and heart attacks. The company’s flagship product is the HeartBeam AIMIGo system, which combines a compact, credit-card-sized ECG device with a smartphone application. The system is designed to record a three-dimensional, vector-based ECG and securely share the results with healthcare professionals for review.